NCT00096005 2014-02-24Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or LymphomasNational Cancer Institute (NCI)Phase 1 Terminated36 enrolled
NCT00019708 2013-12-16Geldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaNational Cancer Institute (NCI)Phase 1 Terminated45 enrolled
NCT00103272 2013-06-0417-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic CancerNational Cancer Institute (NCI)Phase 1 Terminated74 enrolled
NCT00354185 2013-05-16PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or LymphomaNational Cancer Institute (NCI)Phase 1 Terminated36 enrolled